# CAVU Biotherapies, Inc. — Form D

CAVU Biotherapies, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-04. The offering totals $1.5M, of which $50K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-03-04
- Form: D
- Accession: 0001696916-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $50K
- Remaining: $1.4M
- Investors: 1
- Date of first sale: 2019-02-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-334003

## Issuer

- Name: CAVU Biotherapies, Inc.
- CIK: 0001696916
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 8285 El Rio, HOUSTON, TX, 77054
- Phone: 7133802758

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Colleen O'Connor | Director | HOUSTON, TX |
| Colleen O'Connor | Executive Officer | HOUSTON, TX |
| Colleen M O'Connor | Director | Houston, TX |
| Colleen M O'Connor | Executive Officer | Houston, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-03-17](https://search.stillhousedata.com/formd/0001696916-17-000001) | D | $1.5M | $75K |

## More

- [CIK 1696916 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1696916&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001696916-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.